These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 2231918)

  • 1. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin.
    Deresiewicz RL; Stone RM; Aster JC
    J Urol; 1990 Dec; 144(6):1331-3; discussion 1333-4. PubMed ID: 2231918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer.
    Rawls WH; Lamm DL; Lowe BA; Crawford ED; Sarosdy MF; Montie JE; Grossman HB; Scardino PT
    J Urol; 1990 Dec; 144(6):1328-30. PubMed ID: 2231917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary tuberculosis of the penis after intravesical bacillus Calmette-Guerin instillation therapy.
    Yoshida R; Kawasaki H; Miyajima A; Amagai M; Ohyama M
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):77-8. PubMed ID: 18355193
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic Bacillus Calmette-Guerin sepsis manifesting as autoimmunity, 17 months after an intravesical BCG-therapy].
    Goulabchand R; Dufour S; Murez T; Broner J; Rivière S; Guilpain P; Le Quellec A
    Med Mal Infect; 2017 Dec; 47(8):558-561. PubMed ID: 28943176
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer.
    Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
    Eur Urol; 1989; 16(3):161-4. PubMed ID: 2744050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
    Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
    Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent acid-fast bacilli following intravesical bacillus Calmette-Guerin.
    Linn R; Klimberg IW; Wajsman Z
    J Urol; 1989 May; 141(5):1197-8. PubMed ID: 2709508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated Bacillus Calmette-Guérin Infection Detected on FDG PET/CT Following Intravesical Bacillus Calmette-Guérin Therapy.
    Curley M; Bhardwaj H
    Clin Nucl Med; 2020 Jul; 45(7):e323-e324. PubMed ID: 32433172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Granulomatous hepatitis and sepsis secondary to intravesical instillation of bacillus Calmette-Guérin].
    Garmilla-Ezquerra P; Martínez-De Las Cuevas G; Hernández-Hernández JL
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):656-7. PubMed ID: 22683174
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary disease following intravesical BCG treatment.
    Kesten S; Title L; Mullen B; Grossman R
    Thorax; 1990 Sep; 45(9):709-10. PubMed ID: 2218978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment.
    Paterson DL; Patel A
    Aust N Z J Surg; 1998 May; 68(5):340-4. PubMed ID: 9631906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized prospective comparison of oral versus intravesical and percutaneous bacillus Calmette-Guerin for superficial bladder cancer.
    Lamm DL; DeHaven JI; Shriver J; Crispen R; Grau D; Sarosdy MF
    J Urol; 1990 Jul; 144(1):65-7. PubMed ID: 2193172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic bacillus-Calmette Guerin infection after transurethral administration for superficial bladder carcinoma.
    Sakamoto GD; Burden J; Fisher D
    J Urol; 1989 Oct; 142(4):1073-4; discussion 1074-5. PubMed ID: 2795734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiorgan failure following intravesical bacillus Calmette-Guerin administration: a case report].
    Baba Y; Ishizu K; Jojima K; Joko K; Nakamura K; Takihara H; Naito K
    Hinyokika Kiyo; 1992 Sep; 38(9):1063-5. PubMed ID: 1414761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview.
    Witjes JA; vd Meijden AP; Debruyne FM
    Urol Int; 1990; 45(3):129-36. PubMed ID: 2190404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
    Aust TR; Massey JA
    Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoas abscess following intravesical bacillus Calmette-Guerin for bladder cancer: a case report.
    Hakim S; Heaney JA; Heinz T; Zwolak RW
    J Urol; 1993 Jul; 150(1):188-9. PubMed ID: 8510250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterial sepsis following intravesical instillation of bacillus Calmette-Guérin.
    Garyfallou GT
    Acad Emerg Med; 1996 Feb; 3(2):157-60. PubMed ID: 8808378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration.
    Graziano DA; Jacobs D; Lozano RG; Buck RL
    J Urol; 1991 Oct; 146(4):1118-9. PubMed ID: 1895437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
    Lamm DL; DeHaven JI; Shriver J; Sarosdy MF
    J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.